#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epilepsy Neuroendocrine carcinoma metastatic Acute myeloid leukaemia refractory Anal fistula Hereditary motor and sensory neuropathy Metachromatic leukodystrophy Sarcoidosis Soft tissue necrosis Nephrotic syndrome Vulval cancer recurrent Choroidal dystrophy Indolent systemic mastocytosis Hypoparathyroidism Angiosarcoma metastatic Mantle cell lymphoma More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Diagnostics Pituitary-dependent Cushing’s syndrome – Life with Disease Tuberous sclerosis complex MELAS syndrome – Trials in Disease Malignant fibrous histiocytoma – Trials in Disease Behcet’s syndrome Haemophilia B without inhibitors – Basic Information Mastocytosis – Trials in Disease Hepatic angiosarcoma – Life with Disease Von Willebrand’s disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Diclofenac Diethylamine Lactic Acid 64Cu-Dota-Ae105 Hydrocortisone Carcik-Cd19 Cells Zalunfiban Naloxone Camlipixant Umeclidinium Sarilumab ADMILPARANT Pegargiminase Sodium Acetate (1-13C) Contezolid Zilucoplan Sodium Axatilimab AZD4512 Ciclosporin Bi 1015550 Dermatophagoides Farinae More therapies…

    Learn about Your Condition

    Gout Testicular germ cell cancer Liver transplant B-cell lymphoma recurrent MELAS syndrome Thrombotic microangiopathy Habitual abortion Cardiomyopathy Alpha-1 antitrypsin deficiency Rectal adenocarcinoma Mixed-type liposarcoma Indolent systemic mastocytosis Epithelioid sarcoma Hepatic fibrosis VEXAS syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Single-Dose Rabies Vaccine (Inactivated Flury LEP Strain) Immunity After Five Years: Testing Booster Response in Previously Vaccinated Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rabies
    The Netherlands

  • Study on Fecal Microbiota Transfer for Better Diabetes Control in Adults with Type 2 Diabetes After Bariatric Surgery

    Recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Placebo
    France

  • Study on How Etrasimod Arginine is Absorbed in Blood and Breast Milk of Healthy Breastfeeding Women with Ulcerative Colitis and Other Inflammatory Disorders

    Recruiting

    1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Etrasimod Arginine
    Belgium

  • Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Denosumab
    Austria Germany Spain

  • Study on Levosimendan for Improving Survival in Patients with Out-of-Hospital Cardiac Arrest During CPR

    Recruiting

    2 1 1
    Investigated Drugs:
    • Levosimendan
    Sweden

  • Study on Tick-Borne Encephalitis: Evaluating T-Cell Responses Using Cytokine Release Assay in Healthy and Immunosuppressed Patients with TBE Vaccines

    Recruiting

    3 1 1 1
    Sweden
Previous Page
1 … 192 193 194 195 196 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!